Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Pilot Phase IV, Multicenter, Randomized, Double Blind, Placebo-controlled, Parallel Study To Investigate The Correlation Between Ph Control And Heartburn Symptoms After 14 Days Of Proton Pump Inhibitor Treatment In Subjects With Frequent Heartburn

Next Previous
Search
Trial Profile

A Pilot Phase IV, Multicenter, Randomized, Double Blind, Placebo-controlled, Parallel Study To Investigate The Correlation Between Ph Control And Heartburn Symptoms After 14 Days Of Proton Pump Inhibitor Treatment In Subjects With Frequent Heartburn

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Oct 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Esomeprazole (Primary)
  • Indications Heartburn
  • Focus Therapeutic Use
  • Sponsors Pfizer

Most Recent Events

  • 25 Sep 2018 Primary endpoint (Number of Participants With Relief of 24 Hour Heartburn and Without Relief of 24 Hour Heartburn) has been met, according to results published in the Advances in Therapy.
  • 25 Sep 2018 Primary endpoint (Change From Baseline at Day 14 in Percentage of Time Over 24--Hour Period With Intra Gastric pH Greater Than ) has been met, according to results published in the Advances in Therapy.
  • 25 Sep 2018 Results published in the Advances in Therapy

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top